If the Board say no CR needed until mid 2020, I expect a $$$ partnership of sorts to be announced.
$2m won’t be enough to get Euro Phase 2b going and make FDA progress.
Will Sarepta play ball?
Will Ionis come back to the fold?
Licnsing out ATL1103?
Dunno, but if they were all smiling like Cheshire cats at the AGM...something is up.
.
Ann: AGM Presentation 2019, page-56
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.9¢ | 38456 | 1 |
View Market Depth
| Last trade - 09.42am 10/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable